Bionano Genomics Inc

NASDAQ:BNGO 4:00:00 PM EDT

0.42

-0.01 (-2.88%)

7:53:05 PM EDT: $0.42 0.00 (-0.14%)

Market Cap (Intraday)	29.08M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$7.86 Million
Adjusted EPS	-$0.20

See more estimates

10-Day MA	$0.43
50-Day MA	$0.47
200-Day MA	$0.90

See more pivots

Bionano Genomics Inc Stock, NASDAQ:BNGO

9540 Towne Centre Drive, Suite 100, San Diego, California 92121

United States of America

Phone: +1.858.888.7600

Number of Employees: 344

http://www.bionano.com

Description

Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.